The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Terbinafine (Lamisil) Market Research Report 2025
Synopsis
Terbinafine is also known as Terbinafine hydrochloride (Lamisil).It is a synthetic allylamine antifungal.It is highly lipophilic in nature and tends to accumulate in skin, nails, and fatty tissues.Like other allylamines, terbinafine inhibits ergosterol synthesis by inhibiting the fungal squalene monooxygenase (also called squalene epoxidase), an enzyme that is part of the fungal cell wall synthesis pathway.
The global Terbinafine (Lamisil) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Terbinafine (Lamisil) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Terbinafine (Lamisil) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Terbinafine (Lamisil) include Perrigo, Novartis Pharmaceuticals Corporation, Gokul Pharma, TEVA, Mylan Pharmaceuticals, Pfizer, Sivem Pharmaceuticals, Apotex Corporation and Auro Pharma Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Terbinafine (Lamisil), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terbinafine (Lamisil).
Report Scope
The Terbinafine (Lamisil) market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Terbinafine (Lamisil) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Terbinafine (Lamisil) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perrigo
Novartis Pharmaceuticals Corporation
Gokul Pharma
TEVA
Mylan Pharmaceuticals
Pfizer
Sivem Pharmaceuticals
Apotex Corporation
Auro Pharma Inc
PLIVA
Jamp Pharma Corporation
Nu Pharm
Codal Synto
Qd Pharmaceuticals
Pharmel Inc
Smaart Pharmaceutticals
Qilu Pharmaceutical
Qingdao Jinfeng Pharmaceutical
Segment by Type
Oral
External Use
Segment by Application
Fungal Infection Of The Skin And Mucous Membrane
Onychomycosis
Bronchial Asthma
Gynecological Anti-Infection Preparation
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Terbinafine (Lamisil) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Terbinafine (Lamisil) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Terbinafine is also known as Terbinafine hydrochloride (Lamisil).It is a synthetic allylamine antifungal.It is highly lipophilic in nature and tends to accumulate in skin, nails, and fatty tissues.Like other allylamines, terbinafine inhibits ergosterol synthesis by inhibiting the fungal squalene monooxygenase (also called squalene epoxidase), an enzyme that is part of the fungal cell wall synthesis pathway.
The global Terbinafine (Lamisil) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Terbinafine (Lamisil) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Terbinafine (Lamisil) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Terbinafine (Lamisil) include Perrigo, Novartis Pharmaceuticals Corporation, Gokul Pharma, TEVA, Mylan Pharmaceuticals, Pfizer, Sivem Pharmaceuticals, Apotex Corporation and Auro Pharma Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Terbinafine (Lamisil), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Terbinafine (Lamisil).
Report Scope
The Terbinafine (Lamisil) market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Terbinafine (Lamisil) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Terbinafine (Lamisil) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perrigo
Novartis Pharmaceuticals Corporation
Gokul Pharma
TEVA
Mylan Pharmaceuticals
Pfizer
Sivem Pharmaceuticals
Apotex Corporation
Auro Pharma Inc
PLIVA
Jamp Pharma Corporation
Nu Pharm
Codal Synto
Qd Pharmaceuticals
Pharmel Inc
Smaart Pharmaceutticals
Qilu Pharmaceutical
Qingdao Jinfeng Pharmaceutical
Segment by Type
Oral
External Use
Segment by Application
Fungal Infection Of The Skin And Mucous Membrane
Onychomycosis
Bronchial Asthma
Gynecological Anti-Infection Preparation
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Terbinafine (Lamisil) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Terbinafine (Lamisil) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Terbinafine (Lamisil) Market Overview
1.1 Product Overview and Scope of Terbinafine (Lamisil)
1.2 Terbinafine (Lamisil) Segment by Type
1.2.1 Global Terbinafine (Lamisil) Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 External Use
1.3 Terbinafine (Lamisil) Segment by Application
1.3.1 Global Terbinafine (Lamisil) Market Value by Application: (2024-2030)
1.3.2 Fungal Infection Of The Skin And Mucous Membrane
1.3.3 Onychomycosis
1.3.4 Bronchial Asthma
1.3.5 Gynecological Anti-Infection Preparation
1.3.6 Other
1.4 Global Terbinafine (Lamisil) Market Size Estimates and Forecasts
1.4.1 Global Terbinafine (Lamisil) Revenue 2019-2030
1.4.2 Global Terbinafine (Lamisil) Sales 2019-2030
1.4.3 Global Terbinafine (Lamisil) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Terbinafine (Lamisil) Market Competition by Manufacturers
2.1 Global Terbinafine (Lamisil) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Terbinafine (Lamisil) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Terbinafine (Lamisil) Average Price by Manufacturers (2019-2024)
2.4 Global Terbinafine (Lamisil) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Terbinafine (Lamisil), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Terbinafine (Lamisil), Product Type & Application
2.7 Terbinafine (Lamisil) Market Competitive Situation and Trends
2.7.1 Terbinafine (Lamisil) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Terbinafine (Lamisil) Players Market Share by Revenue
2.7.3 Global Terbinafine (Lamisil) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Terbinafine (Lamisil) Retrospective Market Scenario by Region
3.1 Global Terbinafine (Lamisil) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Terbinafine (Lamisil) Global Terbinafine (Lamisil) Sales by Region: 2019-2030
3.2.1 Global Terbinafine (Lamisil) Sales by Region: 2019-2024
3.2.2 Global Terbinafine (Lamisil) Sales by Region: 2025-2030
3.3 Global Terbinafine (Lamisil) Global Terbinafine (Lamisil) Revenue by Region: 2019-2030
3.3.1 Global Terbinafine (Lamisil) Revenue by Region: 2019-2024
3.3.2 Global Terbinafine (Lamisil) Revenue by Region: 2025-2030
3.4 North America Terbinafine (Lamisil) Market Facts & Figures by Country
3.4.1 North America Terbinafine (Lamisil) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Terbinafine (Lamisil) Sales by Country (2019-2030)
3.4.3 North America Terbinafine (Lamisil) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Terbinafine (Lamisil) Market Facts & Figures by Country
3.5.1 Europe Terbinafine (Lamisil) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Terbinafine (Lamisil) Sales by Country (2019-2030)
3.5.3 Europe Terbinafine (Lamisil) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Terbinafine (Lamisil) Market Facts & Figures by Country
3.6.1 Asia Pacific Terbinafine (Lamisil) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Terbinafine (Lamisil) Sales by Country (2019-2030)
3.6.3 Asia Pacific Terbinafine (Lamisil) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Terbinafine (Lamisil) Market Facts & Figures by Country
3.7.1 Latin America Terbinafine (Lamisil) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Terbinafine (Lamisil) Sales by Country (2019-2030)
3.7.3 Latin America Terbinafine (Lamisil) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Terbinafine (Lamisil) Market Facts & Figures by Country
3.8.1 Middle East and Africa Terbinafine (Lamisil) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Terbinafine (Lamisil) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Terbinafine (Lamisil) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Terbinafine (Lamisil) Sales by Type (2019-2030)
4.1.1 Global Terbinafine (Lamisil) Sales by Type (2019-2024)
4.1.2 Global Terbinafine (Lamisil) Sales by Type (2025-2030)
4.1.3 Global Terbinafine (Lamisil) Sales Market Share by Type (2019-2030)
4.2 Global Terbinafine (Lamisil) Revenue by Type (2019-2030)
4.2.1 Global Terbinafine (Lamisil) Revenue by Type (2019-2024)
4.2.2 Global Terbinafine (Lamisil) Revenue by Type (2025-2030)
4.2.3 Global Terbinafine (Lamisil) Revenue Market Share by Type (2019-2030)
4.3 Global Terbinafine (Lamisil) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Terbinafine (Lamisil) Sales by Application (2019-2030)
5.1.1 Global Terbinafine (Lamisil) Sales by Application (2019-2024)
5.1.2 Global Terbinafine (Lamisil) Sales by Application (2025-2030)
5.1.3 Global Terbinafine (Lamisil) Sales Market Share by Application (2019-2030)
5.2 Global Terbinafine (Lamisil) Revenue by Application (2019-2030)
5.2.1 Global Terbinafine (Lamisil) Revenue by Application (2019-2024)
5.2.2 Global Terbinafine (Lamisil) Revenue by Application (2025-2030)
5.2.3 Global Terbinafine (Lamisil) Revenue Market Share by Application (2019-2030)
5.3 Global Terbinafine (Lamisil) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Perrigo
6.1.1 Perrigo Corporation Information
6.1.2 Perrigo Description and Business Overview
6.1.3 Perrigo Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Perrigo Terbinafine (Lamisil) Product Portfolio
6.1.5 Perrigo Recent Developments/Updates
6.2 Novartis Pharmaceuticals Corporation
6.2.1 Novartis Pharmaceuticals Corporation Corporation Information
6.2.2 Novartis Pharmaceuticals Corporation Description and Business Overview
6.2.3 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product Portfolio
6.2.5 Novartis Pharmaceuticals Corporation Recent Developments/Updates
6.3 Gokul Pharma
6.3.1 Gokul Pharma Corporation Information
6.3.2 Gokul Pharma Description and Business Overview
6.3.3 Gokul Pharma Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Gokul Pharma Terbinafine (Lamisil) Product Portfolio
6.3.5 Gokul Pharma Recent Developments/Updates
6.4 TEVA
6.4.1 TEVA Corporation Information
6.4.2 TEVA Description and Business Overview
6.4.3 TEVA Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 TEVA Terbinafine (Lamisil) Product Portfolio
6.4.5 TEVA Recent Developments/Updates
6.5 Mylan Pharmaceuticals
6.5.1 Mylan Pharmaceuticals Corporation Information
6.5.2 Mylan Pharmaceuticals Description and Business Overview
6.5.3 Mylan Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Pharmaceuticals Terbinafine (Lamisil) Product Portfolio
6.5.5 Mylan Pharmaceuticals Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Terbinafine (Lamisil) Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Sivem Pharmaceuticals
6.6.1 Sivem Pharmaceuticals Corporation Information
6.6.2 Sivem Pharmaceuticals Description and Business Overview
6.6.3 Sivem Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sivem Pharmaceuticals Terbinafine (Lamisil) Product Portfolio
6.7.5 Sivem Pharmaceuticals Recent Developments/Updates
6.8 Apotex Corporation
6.8.1 Apotex Corporation Corporation Information
6.8.2 Apotex Corporation Description and Business Overview
6.8.3 Apotex Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Apotex Corporation Terbinafine (Lamisil) Product Portfolio
6.8.5 Apotex Corporation Recent Developments/Updates
6.9 Auro Pharma Inc
6.9.1 Auro Pharma Inc Corporation Information
6.9.2 Auro Pharma Inc Description and Business Overview
6.9.3 Auro Pharma Inc Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Auro Pharma Inc Terbinafine (Lamisil) Product Portfolio
6.9.5 Auro Pharma Inc Recent Developments/Updates
6.10 PLIVA
6.10.1 PLIVA Corporation Information
6.10.2 PLIVA Description and Business Overview
6.10.3 PLIVA Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 PLIVA Terbinafine (Lamisil) Product Portfolio
6.10.5 PLIVA Recent Developments/Updates
6.11 Jamp Pharma Corporation
6.11.1 Jamp Pharma Corporation Corporation Information
6.11.2 Jamp Pharma Corporation Terbinafine (Lamisil) Description and Business Overview
6.11.3 Jamp Pharma Corporation Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jamp Pharma Corporation Terbinafine (Lamisil) Product Portfolio
6.11.5 Jamp Pharma Corporation Recent Developments/Updates
6.12 Nu Pharm
6.12.1 Nu Pharm Corporation Information
6.12.2 Nu Pharm Terbinafine (Lamisil) Description and Business Overview
6.12.3 Nu Pharm Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Nu Pharm Terbinafine (Lamisil) Product Portfolio
6.12.5 Nu Pharm Recent Developments/Updates
6.13 Codal Synto
6.13.1 Codal Synto Corporation Information
6.13.2 Codal Synto Terbinafine (Lamisil) Description and Business Overview
6.13.3 Codal Synto Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Codal Synto Terbinafine (Lamisil) Product Portfolio
6.13.5 Codal Synto Recent Developments/Updates
6.14 Qd Pharmaceuticals
6.14.1 Qd Pharmaceuticals Corporation Information
6.14.2 Qd Pharmaceuticals Terbinafine (Lamisil) Description and Business Overview
6.14.3 Qd Pharmaceuticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Qd Pharmaceuticals Terbinafine (Lamisil) Product Portfolio
6.14.5 Qd Pharmaceuticals Recent Developments/Updates
6.15 Pharmel Inc
6.15.1 Pharmel Inc Corporation Information
6.15.2 Pharmel Inc Terbinafine (Lamisil) Description and Business Overview
6.15.3 Pharmel Inc Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Pharmel Inc Terbinafine (Lamisil) Product Portfolio
6.15.5 Pharmel Inc Recent Developments/Updates
6.16 Smaart Pharmaceutticals
6.16.1 Smaart Pharmaceutticals Corporation Information
6.16.2 Smaart Pharmaceutticals Terbinafine (Lamisil) Description and Business Overview
6.16.3 Smaart Pharmaceutticals Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Smaart Pharmaceutticals Terbinafine (Lamisil) Product Portfolio
6.16.5 Smaart Pharmaceutticals Recent Developments/Updates
6.17 Qilu Pharmaceutical
6.17.1 Qilu Pharmaceutical Corporation Information
6.17.2 Qilu Pharmaceutical Terbinafine (Lamisil) Description and Business Overview
6.17.3 Qilu Pharmaceutical Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Qilu Pharmaceutical Terbinafine (Lamisil) Product Portfolio
6.17.5 Qilu Pharmaceutical Recent Developments/Updates
6.18 Qingdao Jinfeng Pharmaceutical
6.18.1 Qingdao Jinfeng Pharmaceutical Corporation Information
6.18.2 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Description and Business Overview
6.18.3 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product Portfolio
6.18.5 Qingdao Jinfeng Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Terbinafine (Lamisil) Industry Chain Analysis
7.2 Terbinafine (Lamisil) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Terbinafine (Lamisil) Production Mode & Process
7.4 Terbinafine (Lamisil) Sales and Marketing
7.4.1 Terbinafine (Lamisil) Sales Channels
7.4.2 Terbinafine (Lamisil) Distributors
7.5 Terbinafine (Lamisil) Customers
8 Terbinafine (Lamisil) Market Dynamics
8.1 Terbinafine (Lamisil) Industry Trends
8.2 Terbinafine (Lamisil) Market Drivers
8.3 Terbinafine (Lamisil) Market Challenges
8.4 Terbinafine (Lamisil) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Terbinafine (Lamisil) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Terbinafine (Lamisil) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Terbinafine (Lamisil) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Terbinafine (Lamisil) Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Terbinafine (Lamisil) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Terbinafine (Lamisil) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Terbinafine (Lamisil) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Terbinafine (Lamisil) Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Terbinafine (Lamisil), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Terbinafine (Lamisil), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Terbinafine (Lamisil), Product Type & Application
Table 12. Global Key Manufacturers of Terbinafine (Lamisil), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Terbinafine (Lamisil) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Terbinafine (Lamisil) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Terbinafine (Lamisil) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Terbinafine (Lamisil) Sales by Region (2019-2024) & (KG)
Table 18. Global Terbinafine (Lamisil) Sales Market Share by Region (2019-2024)
Table 19. Global Terbinafine (Lamisil) Sales by Region (2025-2030) & (KG)
Table 20. Global Terbinafine (Lamisil) Sales Market Share by Region (2025-2030)
Table 21. Global Terbinafine (Lamisil) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Terbinafine (Lamisil) Revenue Market Share by Region (2019-2024)
Table 23. Global Terbinafine (Lamisil) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Terbinafine (Lamisil) Revenue Market Share by Region (2025-2030)
Table 25. North America Terbinafine (Lamisil) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Terbinafine (Lamisil) Sales by Country (2019-2024) & (KG)
Table 27. North America Terbinafine (Lamisil) Sales by Country (2025-2030) & (KG)
Table 28. North America Terbinafine (Lamisil) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Terbinafine (Lamisil) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Terbinafine (Lamisil) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Terbinafine (Lamisil) Sales by Country (2019-2024) & (KG)
Table 32. Europe Terbinafine (Lamisil) Sales by Country (2025-2030) & (KG)
Table 33. Europe Terbinafine (Lamisil) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Terbinafine (Lamisil) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Terbinafine (Lamisil) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Terbinafine (Lamisil) Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Terbinafine (Lamisil) Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Terbinafine (Lamisil) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Terbinafine (Lamisil) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Terbinafine (Lamisil) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Terbinafine (Lamisil) Sales by Country (2019-2024) & (KG)
Table 42. Latin America Terbinafine (Lamisil) Sales by Country (2025-2030) & (KG)
Table 43. Latin America Terbinafine (Lamisil) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Terbinafine (Lamisil) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Terbinafine (Lamisil) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Terbinafine (Lamisil) Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Terbinafine (Lamisil) Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Terbinafine (Lamisil) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Terbinafine (Lamisil) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Terbinafine (Lamisil) Sales (KG) by Type (2019-2024)
Table 51. Global Terbinafine (Lamisil) Sales (KG) by Type (2025-2030)
Table 52. Global Terbinafine (Lamisil) Sales Market Share by Type (2019-2024)
Table 53. Global Terbinafine (Lamisil) Sales Market Share by Type (2025-2030)
Table 54. Global Terbinafine (Lamisil) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Terbinafine (Lamisil) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Terbinafine (Lamisil) Revenue Market Share by Type (2019-2024)
Table 57. Global Terbinafine (Lamisil) Revenue Market Share by Type (2025-2030)
Table 58. Global Terbinafine (Lamisil) Price (US$/G) by Type (2019-2024)
Table 59. Global Terbinafine (Lamisil) Price (US$/G) by Type (2025-2030)
Table 60. Global Terbinafine (Lamisil) Sales (KG) by Application (2019-2024)
Table 61. Global Terbinafine (Lamisil) Sales (KG) by Application (2025-2030)
Table 62. Global Terbinafine (Lamisil) Sales Market Share by Application (2019-2024)
Table 63. Global Terbinafine (Lamisil) Sales Market Share by Application (2025-2030)
Table 64. Global Terbinafine (Lamisil) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Terbinafine (Lamisil) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Terbinafine (Lamisil) Revenue Market Share by Application (2019-2024)
Table 67. Global Terbinafine (Lamisil) Revenue Market Share by Application (2025-2030)
Table 68. Global Terbinafine (Lamisil) Price (US$/G) by Application (2019-2024)
Table 69. Global Terbinafine (Lamisil) Price (US$/G) by Application (2025-2030)
Table 70. Perrigo Corporation Information
Table 71. Perrigo Description and Business Overview
Table 72. Perrigo Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. Perrigo Terbinafine (Lamisil) Product
Table 74. Perrigo Recent Developments/Updates
Table 75. Novartis Pharmaceuticals Corporation Corporation Information
Table 76. Novartis Pharmaceuticals Corporation Description and Business Overview
Table 77. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. Novartis Pharmaceuticals Corporation Terbinafine (Lamisil) Product
Table 79. Novartis Pharmaceuticals Corporation Recent Developments/Updates
Table 80. Gokul Pharma Corporation Information
Table 81. Gokul Pharma Description and Business Overview
Table 82. Gokul Pharma Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. Gokul Pharma Terbinafine (Lamisil) Product
Table 84. Gokul Pharma Recent Developments/Updates
Table 85. TEVA Corporation Information
Table 86. TEVA Description and Business Overview
Table 87. TEVA Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. TEVA Terbinafine (Lamisil) Product
Table 89. TEVA Recent Developments/Updates
Table 90. Mylan Pharmaceuticals Corporation Information
Table 91. Mylan Pharmaceuticals Description and Business Overview
Table 92. Mylan Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. Mylan Pharmaceuticals Terbinafine (Lamisil) Product
Table 94. Mylan Pharmaceuticals Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. Pfizer Terbinafine (Lamisil) Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Sivem Pharmaceuticals Corporation Information
Table 101. Sivem Pharmaceuticals Description and Business Overview
Table 102. Sivem Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. Sivem Pharmaceuticals Terbinafine (Lamisil) Product
Table 104. Sivem Pharmaceuticals Recent Developments/Updates
Table 105. Apotex Corporation Corporation Information
Table 106. Apotex Corporation Description and Business Overview
Table 107. Apotex Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. Apotex Corporation Terbinafine (Lamisil) Product
Table 109. Apotex Corporation Recent Developments/Updates
Table 110. Auro Pharma Inc Corporation Information
Table 111. Auro Pharma Inc Description and Business Overview
Table 112. Auro Pharma Inc Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 113. Auro Pharma Inc Terbinafine (Lamisil) Product
Table 114. Auro Pharma Inc Recent Developments/Updates
Table 115. PLIVA Corporation Information
Table 116. PLIVA Description and Business Overview
Table 117. PLIVA Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 118. PLIVA Terbinafine (Lamisil) Product
Table 119. PLIVA Recent Developments/Updates
Table 120. Jamp Pharma Corporation Corporation Information
Table 121. Jamp Pharma Corporation Description and Business Overview
Table 122. Jamp Pharma Corporation Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 123. Jamp Pharma Corporation Terbinafine (Lamisil) Product
Table 124. Jamp Pharma Corporation Recent Developments/Updates
Table 125. Nu Pharm Corporation Information
Table 126. Nu Pharm Description and Business Overview
Table 127. Nu Pharm Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 128. Nu Pharm Terbinafine (Lamisil) Product
Table 129. Nu Pharm Recent Developments/Updates
Table 130. Codal Synto Corporation Information
Table 131. Codal Synto Description and Business Overview
Table 132. Codal Synto Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 133. Codal Synto Terbinafine (Lamisil) Product
Table 134. Codal Synto Recent Developments/Updates
Table 135. Qd Pharmaceuticals Corporation Information
Table 136. Qd Pharmaceuticals Description and Business Overview
Table 137. Qd Pharmaceuticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 138. Qd Pharmaceuticals Terbinafine (Lamisil) Product
Table 139. Qd Pharmaceuticals Recent Developments/Updates
Table 140. Pharmel Inc Corporation Information
Table 141. Pharmel Inc Description and Business Overview
Table 142. Pharmel Inc Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 143. Pharmel Inc Terbinafine (Lamisil) Product
Table 144. Pharmel Inc Recent Developments/Updates
Table 145. Smaart Pharmaceutticals Corporation Information
Table 146. Smaart Pharmaceutticals Description and Business Overview
Table 147. Smaart Pharmaceutticals Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 148. Smaart Pharmaceutticals Terbinafine (Lamisil) Product
Table 149. Smaart Pharmaceutticals Recent Developments/Updates
Table 150. Qilu Pharmaceutical Corporation Information
Table 151. Qilu Pharmaceutical Description and Business Overview
Table 152. Qilu Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 153. Qilu Pharmaceutical Terbinafine (Lamisil) Product
Table 154. Qilu Pharmaceutical Recent Developments/Updates
Table 155. Qingdao Jinfeng Pharmaceutical Corporation Information
Table 156. Qingdao Jinfeng Pharmaceutical Description and Business Overview
Table 157. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 158. Qingdao Jinfeng Pharmaceutical Terbinafine (Lamisil) Product
Table 159. Qingdao Jinfeng Pharmaceutical Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Terbinafine (Lamisil) Distributors List
Table 163. Terbinafine (Lamisil) Customers List
Table 164. Terbinafine (Lamisil) Market Trends
Table 165. Terbinafine (Lamisil) Market Drivers
Table 166. Terbinafine (Lamisil) Market Challenges
Table 167. Terbinafine (Lamisil) Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Terbinafine (Lamisil)
Figure 2. Global Terbinafine (Lamisil) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Terbinafine (Lamisil) Market Share by Type in 2023 & 2030
Figure 4. Oral Product Picture
Figure 5. External Use Product Picture
Figure 6. Global Terbinafine (Lamisil) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Terbinafine (Lamisil) Market Share by Application in 2023 & 2030
Figure 8. Fungal Infection Of The Skin And Mucous Membrane
Figure 9. Onychomycosis
Figure 10. Bronchial Asthma
Figure 11. Gynecological Anti-Infection Preparation
Figure 12. Other
Figure 13. Global Terbinafine (Lamisil) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Terbinafine (Lamisil) Market Size (2019-2030) & (US$ Million)
Figure 15. Global Terbinafine (Lamisil) Sales (2019-2030) & (KG)
Figure 16. Global Terbinafine (Lamisil) Average Price (US$/G) & (2019-2030)
Figure 17. Terbinafine (Lamisil) Report Years Considered
Figure 18. Terbinafine (Lamisil) Sales Share by Manufacturers in 2023
Figure 19. Global Terbinafine (Lamisil) Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Terbinafine (Lamisil) Players: Market Share by Revenue in 2023
Figure 21. Terbinafine (Lamisil) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Terbinafine (Lamisil) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Terbinafine (Lamisil) Sales Market Share by Country (2019-2030)
Figure 24. North America Terbinafine (Lamisil) Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Terbinafine (Lamisil) Sales Market Share by Country (2019-2030)
Figure 28. Europe Terbinafine (Lamisil) Revenue Market Share by Country (2019-2030)
Figure 29. Germany Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Terbinafine (Lamisil) Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Terbinafine (Lamisil) Revenue Market Share by Region (2019-2030)
Figure 36. China Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Terbinafine (Lamisil) Sales Market Share by Country (2019-2030)
Figure 47. Latin America Terbinafine (Lamisil) Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Terbinafine (Lamisil) Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Terbinafine (Lamisil) Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. UAE Terbinafine (Lamisil) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Terbinafine (Lamisil) by Type (2019-2030)
Figure 57. Global Revenue Market Share of Terbinafine (Lamisil) by Type (2019-2030)
Figure 58. Global Terbinafine (Lamisil) Price (US$/G) by Type (2019-2030)
Figure 59. Global Sales Market Share of Terbinafine (Lamisil) by Application (2019-2030)
Figure 60. Global Revenue Market Share of Terbinafine (Lamisil) by Application (2019-2030)
Figure 61. Global Terbinafine (Lamisil) Price (US$/G) by Application (2019-2030)
Figure 62. Terbinafine (Lamisil) Value Chain
Figure 63. Terbinafine (Lamisil) Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
